STIM
Neuronetics Inc
NASDAQ: STIM · HEALTHCARE · MEDICAL DEVICES
$1.94
+14.12% today
Updated 2026-04-30
Market cap
$117.59M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$1 – $5
Volume
1.9M
Neuronetics Inc (STIM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-26.20%
Operating margin
-11.10%
ROE
-134.90%
ROA
-13.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $34.23M | $-11.23M | 80.65% | -27.28% | -32.82% |
| 2017 | $40.43M | $-16.06M | 76.18% | -33.66% | -39.72% |
| 2018 | $52.78M | $-24.10M | 76.42% | -37.58% | -45.66% |
| 2019 | $62.66M | $-29.04M | 75.44% | -42.98% | -46.35% |
| 2020 | $49.24M | $-27.45M | 76.54% | -45.30% | -55.75% |
| 2021 | $55.31M | $-31.19M | 78.93% | -49.83% | -56.39% |
| 2022 | $65.21M | $-37.16M | 76.26% | -53.85% | -56.99% |
| 2023 | $71.35M | $-30.19M | 72.47% | -42.82% | -42.31% |
| 2024 | $74.89M | $-43.71M | 72.32% | -46.15% | -58.36% |
| 2025 | $149.16M | $-39.00M | 48.48% | -21.08% | -26.15% |